Page last updated: 2024-10-30

metformin and Thalassemias

metformin has been researched along with Thalassemias in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin, a biguanide, was the most frequently used drug (47."1.72The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network. ( Banchev, A; Campisi, S; Daar, S; De Sanctis, V; Delaporta, P; Galati, MC; Karimi, M; Kattamis, A; Kattamis, C; Messina, G; Raiola, G; Saki, F; Sapunarova, K; Soliman, A; Tzoulis, P; Yassin, MA; Zarei, T, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
De Sanctis, V1
Soliman, A1
Tzoulis, P1
Daar, S1
Kattamis, A1
Delaporta, P1
Karimi, M1
Yassin, MA1
Zarei, T1
Saki, F1
Sapunarova, K1
Banchev, A1
Galati, MC1
Raiola, G1
Messina, G1
Campisi, S1
Kattamis, C1
Fung, EB1
Ahmad, T1
Killilea, DW1
Hussain, R1
Lal, A1

Other Studies

2 other studies available for metformin and Thalassemias

ArticleYear
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.
    Acta bio-medica : Atenei Parmensis, 2022, 05-11, Volume: 93, Issue:2

    Topics: beta-Thalassemia; Diabetes Mellitus; Glucose; Humans; Insulin; Metformin; Preliminary Data; Retrospe

2022
Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    British journal of haematology, 2020, Volume: 190, Issue:3

    Topics: Adolescent; Adult; Biomarkers; Blood Glucose; C-Peptide; Child; Diabetes Complications; Diabetes Mel

2020